Literature DB >> 10155607

Quality-of-life considerations in the treatment of asthma.

E F Juniper1.   

Abstract

There is a growing body of evidence showing that the conventional clinical indices of asthma severity (airway calibre, symptoms, airway responsiveness, etc.) correlate only weakly with how patients are actually feeling and how they are able to function in their daily lives because of their asthma. When assessing and treating asthma, it is certainly important to evaluate the airways. However, it is equally important to evaluate the impact of the condition on the patients themselves. There are now a number of health-related quality-of-life instruments, with strong measurement properties, that may be used in both clinical studies and practice. They provide scientifically sound and valid information about patients' experience that complements conventional clinical measures.

Entities:  

Mesh:

Year:  1995        PMID: 10155607     DOI: 10.2165/00019053-199508020-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  34 in total

1.  A life activities questionnaire for adult asthma.

Authors:  T L Creer; J K Wigal; H Kotses; K McConnaughy; J A Winder
Journal:  J Asthma       Date:  1992       Impact factor: 2.515

2.  Measuring health status: what are the necessary measurement properties?

Authors:  G H Guyatt; B Kirshner; R Jaeschke
Journal:  J Clin Epidemiol       Date:  1992-12       Impact factor: 6.437

3.  Social and emotional impact of childhood asthma.

Authors:  A Nocon
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

4.  A scale for the measurement of quality of life in adults with asthma.

Authors:  G B Marks; S M Dunn; A J Woolcock
Journal:  J Clin Epidemiol       Date:  1992-05       Impact factor: 6.437

5.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

Review 6.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

Review 7.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

8.  Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics.

Authors:  M E Hyland; C A Kenyon; P A Jacobs
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

9.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

10.  Developing a quality-of-life questionnaire for patients with respiratory illness.

Authors:  A R Maillé; A A Kaptein; C J Koning; A H Zwinderman
Journal:  Monaldi Arch Chest Dis       Date:  1994-02
View more
  9 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  Knowledge, self-management, compliance and quality of life in asthma: a cross-sectional study of the French version of the Asthma Quality of Life Questionnaire.

Authors:  C Leroyer; T Lebrun; A Proust; X Lenne; E Lucas; G Rio; J D Dewitte; J Clavier
Journal:  Qual Life Res       Date:  1998-04       Impact factor: 4.147

Review 3.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

Review 4.  Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.

Authors:  I Côté; J P Grégoire; J Moisan
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

5.  Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.

Authors:  Shih-Feng Chiu; Christina M L Kelton; Jeff Jianfei Guo; Patricia R Wigle; Alex C Lin; Sheryl L Szeinbach
Journal:  Am Health Drug Benefits       Date:  2011-05

6.  The relationship between asthma severity, family functioning and the health-related quality of life of children with asthma.

Authors:  M G Sawyer; N Spurrier; L Whaites; D Kennedy; A J Martin; P Baghurst
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

7.  Development and validation of the living with chronic obstructive pulmonary disease questionnaire.

Authors:  Stephen P McKenna; David M Meads; Lynda C Doward; James Twiss; Robin Pokrzywinski; Dennis Revicki; Cameron J Hunter; G Alastair Glendenning
Journal:  Qual Life Res       Date:  2011-02-11       Impact factor: 4.147

8.  Agreement between a generic and disease-specific quality-of-life instrument: the 15D and the SGRQ in asthmatic patients.

Authors:  K Ritva; R Pekka; S Harri
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

9.  Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation?

Authors:  J J Caro; I Caro; J Caro; F Wouters; E F Juniper
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.